Meningitis Vaccine Project
This project is looking at protection levels following introduction of a new MenA vaccine in Burkina Faso, a process which is being led by the Meningitis Vaccine Project
MVP is an international collaboration which aims to reduce and control epidemic meningitis in several countries in Africa, where thousands of people die in large waves of disease.
This MRF project will provide essential data on the duration of protection of this new vaccine in one of the chosen African countries, Burkina Faso.
In the study clinic in front of the exam cabins. From left to right: Dr Aline Ouoba (Centre Muraz, serology), Dr Judith Mueller (EHESP, MRF principal applicant, investigator), Dr Hervé Kpoda (Centre Muraz, head of the outpatient clinic, investigator), Minata Coulibaly (Center Muraz, study nurse)